JPWO2021108447A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021108447A5
JPWO2021108447A5 JP2022530672A JP2022530672A JPWO2021108447A5 JP WO2021108447 A5 JPWO2021108447 A5 JP WO2021108447A5 JP 2022530672 A JP2022530672 A JP 2022530672A JP 2022530672 A JP2022530672 A JP 2022530672A JP WO2021108447 A5 JPWO2021108447 A5 JP WO2021108447A5
Authority
JP
Japan
Prior art keywords
masp
composition
cdr
subject
stem cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022530672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503611A5 (https=
JP2023503611A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/062082 external-priority patent/WO2021108447A1/en
Publication of JP2023503611A publication Critical patent/JP2023503611A/ja
Publication of JP2023503611A5 publication Critical patent/JP2023503611A5/ja
Publication of JPWO2021108447A5 publication Critical patent/JPWO2021108447A5/ja
Priority to JP2026000091A priority Critical patent/JP2026062897A/ja
Pending legal-status Critical Current

Links

Images

JP2022530672A 2019-11-26 2020-11-24 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法 Pending JP2023503611A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026000091A JP2026062897A (ja) 2019-11-26 2026-01-05 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962940720P 2019-11-26 2019-11-26
US201962940735P 2019-11-26 2019-11-26
US62/940,720 2019-11-26
US62/940,735 2019-11-26
PCT/US2020/062082 WO2021108447A1 (en) 2019-11-26 2020-11-24 Methods for treating and/or preventing idiopathic pneumonia syndrome (ips) and/or capillary leak syndrome (cls) and/or engraftment syndrome (es) and/or fluid overload (fo) associated with hematopoietic stem cell transplant

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026000091A Division JP2026062897A (ja) 2019-11-26 2026-01-05 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法

Publications (3)

Publication Number Publication Date
JP2023503611A JP2023503611A (ja) 2023-01-31
JP2023503611A5 JP2023503611A5 (https=) 2023-07-27
JPWO2021108447A5 true JPWO2021108447A5 (https=) 2023-07-27

Family

ID=76130747

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022530672A Pending JP2023503611A (ja) 2019-11-26 2020-11-24 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法
JP2026000091A Pending JP2026062897A (ja) 2019-11-26 2026-01-05 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026000091A Pending JP2026062897A (ja) 2019-11-26 2026-01-05 造血幹細胞移植に関連する特発性肺炎症候群（ｉｐｓ）および／または毛細血管漏出症候群（ｃｌｓ）および／または生着症候群（ｅｓ）および／または体液過剰（ｆｏ）を治療および／または予防するための方法

Country Status (13)

Country Link
US (2) US20220064330A1 (https=)
EP (1) EP4065165A4 (https=)
JP (2) JP2023503611A (https=)
KR (1) KR20220104201A (https=)
CN (1) CN115335077A (https=)
AU (1) AU2020391175A1 (https=)
BR (1) BR112022010078A2 (https=)
CA (1) CA3159152A1 (https=)
CL (4) CL2022001355A1 (https=)
IL (1) IL293363A (https=)
JO (1) JOP20220113A1 (https=)
MX (1) MX2022006334A (https=)
WO (1) WO2021108447A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023108028A2 (en) 2021-12-10 2023-06-15 Omeros Corporation Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919094B2 (en) * 2004-06-10 2011-04-05 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
EP2704743B1 (en) * 2011-05-04 2020-03-11 Omeros Corporation Compositions for inhibiting masp-2 dependent complement acitivation
CN108472347B (zh) * 2015-11-09 2023-09-05 奥默罗斯公司 用于治疗与masp-2依赖性补体活化相关的病况的方法
US10736960B2 (en) * 2016-01-05 2020-08-11 Omeros Corporation Methods for inhibiting fibrosis in a subject in need thereof
RU2018145364A (ru) * 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
JOP20170170B1 (ar) * 2016-08-31 2022-09-15 Omeros Corp صيغ لجسم مضاد تثبيطية لـ masp-2 بتركيز عالي ولزوجة منخفضة وأطقم، وطرق
EP3526249A4 (en) * 2016-10-17 2020-07-01 Musc Foundation for Research Development COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INJURY ASSOCIATED WITH A GRAFT
CA3055781A1 (en) * 2017-03-14 2018-09-20 Bioverativ Usa Inc. Methods for treating complement-mediated diseases and disorders
TWI818919B (zh) * 2017-08-15 2023-10-21 美商歐米諾斯公司 用於治療和／ 或預防與造血幹細胞移植有關的移植物抗宿主病和／ 或瀰漫性肺泡出血和／ 或靜脈閉塞性病的方法
EP3717004A4 (en) * 2017-12-01 2021-12-01 Children's Hospital Medical Center COMPOSITIONS FOR BLOCKING INTERERONS AND THEIR METHODS OF USE

Similar Documents

Publication Publication Date Title
JP2023123627A5 (https=)
RU2563830C2 (ru) Лечение остеоартрита и боли
JP7293122B2 (ja) 補体が媒介する疾患および障害を処置するための方法
RU2650767C2 (ru) Интерлейкин-13-связывающие белки
DK2391650T3 (en) Methods of treating gout
TW201124427A (en) IL-1 binding proteins
JP2011506483A5 (https=)
TW201014602A (en) Prostaglandin E2 binding proteins and uses thereof
TW201002344A (en) Monoclonal antibodies against the RGM a protein and uses thereof
JP2021510523A5 (https=)
CN111886252A (zh) 促进胰岛细胞生长的方法
WO2011112850A2 (en) Humanized and chimeric anti-properdin antibodies
TWI834254B (zh) α-烯醇酶拮抗劑治療纖維化疾病之用途
JPWO2022053654A5 (https=)
CN116322713A (zh) 使用抗组织因子抗体进行炎性疾病治疗
JPWO2021108447A5 (https=)
JP2022520572A (ja) 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置
TW202421661A (zh) Igf1r抗體
JPWO2019140216A5 (https=)
JPWO2019215701A5 (https=)
JPWO2023079485A5 (https=)
WO2026082814A1 (en) Anti- igfbp7 antibodies and uses thereof
WO2025240780A1 (en) Antibodies and antibody fragments that bind ige
NZ614207B2 (en) Treatment of osteoarthritis and pain
NZ760818A (en) Methods for inhibiting fibrosis in a subject in need thereof